Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
All content for On The Pen With Dave Knapp is the property of Dave Knapp Man On The Mounjaro, Bleav and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Unlocking Zepbound Insurance Coverage + More GLP-1 Good News // otp twd 7.1.25
On The Pen With Dave Knapp
33 minutes 37 seconds
1 month ago
Unlocking Zepbound Insurance Coverage + More GLP-1 Good News // otp twd 7.1.25
If you are losing Zepbound coverage, you have got to check this podcast out! Plus Dave covers this week's news in obesity medicine!
On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
